|
[1]
|
Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson’s
Disease
Current Neuropharmacology,
2023
DOI:10.2174/1570159X21666221229154830
|
|
|
|
|
[2]
|
Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson’s
Disease
Current Neuropharmacology,
2023
DOI:10.2174/1570159X21666221229154830
|
|
|
|
|
[3]
|
CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis
Frontiers in Psychology,
2022
DOI:10.3389/fpsyg.2021.768748
|
|
|
|
|
[4]
|
Medicinal chemistry strategies for the development of phosphodiesterase 10A (PDE10A) inhibitors - An update of recent progress
European Journal of Medicinal Chemistry,
2021
DOI:10.1016/j.ejmech.2021.113155
|
|
|
|
|
[5]
|
Medicinal chemistry strategies for the development of phosphodiesterase 10A (PDE10A) inhibitors - An update of recent progress
European Journal of Medicinal Chemistry,
2021
DOI:10.1016/j.ejmech.2021.113155
|
|
|
|
|
[6]
|
Pharmacogenomics of drugs used to treat brain disorders
Expert Review of Precision Medicine and Drug Development,
2020
DOI:10.1080/23808993.2020.1738217
|
|
|
|
|
[7]
|
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
International Journal of Molecular Sciences,
2020
DOI:10.3390/ijms21093059
|
|
|
|
|
[8]
|
Pharmacoepigenetics
2019
DOI:10.1016/B978-0-12-813939-4.00022-X
|
|
|
|
|
[9]
|
Pharmacogenetics
Advances in Pharmacology,
2018
DOI:10.1016/bs.apha.2018.03.003
|
|
|
|
|
[10]
|
Population-level pharmacogenomics for precision drug development in dementia
Expert Review of Precision Medicine and Drug Development,
2018
DOI:10.1080/23808993.2018.1468218
|
|
|
|
|
[11]
|
Evaluation of gas chromatography mass spectrometry and pattern recognition for the identification of bladder cancer from urine headspace
Anal. Methods,
2016
DOI:10.1039/C6AY00400H
|
|
|
|
|
[12]
|
Melatonin, Neuroprotective Agents and Antidepressant Therapy
2016
DOI:10.1007/978-81-322-2803-5_35
|
|
|
|
|
[13]
|
Preventive and Predictive Genetics: Towards Personalised Medicine
Advances in Predictive, Preventive and Personalised Medicine,
2015
DOI:10.1007/978-3-319-15344-5_8
|
|
|
|
|
[14]
|
Preventive and Predictive Genetics: Towards Personalised Medicine
Advances in Predictive, Preventive and Personalised Medicine,
2015
DOI:10.1007/978-3-319-15344-5_8
|
|
|
|
|
[15]
|
Epigenomic Networking in Drug Development: From Pathogenic Mechanisms to Pharmacogenomics
Drug Development Research,
2014
DOI:10.1002/ddr.21219
|
|
|
|
|
[16]
|
Epigenomic Networking in Drug Development: From Pathogenic Mechanisms to Pharmacogenomics
Drug Development Research,
2014
DOI:10.1002/ddr.21219
|
|
|
|